Solubilization of a Tissue-Bound Activator of Plasminogen under Physiological Conditions

Solubilization of a Tissue-Bound Activator of Plasminogen under Physiological Conditions

Saved in:

Bibliographic Details
Main Authors:	E.E. Rickli, I. Baunok, H. Zaugg
Format:	Article
Language:	deu
Published:	Swiss Chemical Society 1967-09-01
Series:	CHIMIA
Online Access:	https://www.chimia.ch/chimia/article/view/8627
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Plasminogen Activator from Porcine Heart Tissue
by: P. Cuendet, et al.
Published: (1976-02-01)

Plasminogen and Plasmin as Key-Substances within the Fibrinolytic System
by: Egon E. Rickli
Published: (1978-01-01)

Tissue Plasminogen Activator Toxicity after Submacular Hemorrhage Repair
by: Yasmin Islam, et al.
Published: (2021-07-01)

Orolingual angioedema as a complication of systemic thrombolytic therapy with recombinant tissue plasminogen activator
by: E. A. Kovaleva, et al.
Published: (2023-11-01)

Serum tissue plasminogen activator after cycling with blood flow restriction
by: Josh B Landers, et al.
Published: (2025-02-01)

Pars plana vitrectomy with tissue plasminogen activator for traumatic submacular hemorrhage
by: Wilson X. Wang, et al.
Published: (2025-09-01)

Tissue plasminogen activator and patients with acute ischemic stroke: The litigation landscape
by: Latha Ganti, et al.
Published: (2022-02-01)

Plasminogen activators in acute management of thrombosis
by: E. O. Taratukhin
Published: (2013-06-01)

Successful Use of Tissue Plasminogen Activator in an Adolescent Male with Pyogenic Liver Abscess
by: Janine Zee-Cheng, et al.
Published: (2019-01-01)

Physico-Chemical and Biological Properties of Biosimilar and Reference Tissue Plasminogen Activator Products
by: V. D. Gusarova, et al.
Published: (2019-03-01)

Stereotactic fibrinolysis of spontaneous intracerebral hematoma using infusion of recombinant tissue plasminogen activator
by: José Augusto Nasser, et al.
Published: (2002-06-01)

Tissue plasminogen activator associated pulmonary hemorrhage in patient with ACTA2-associated arteriopathy
by: Travis G. Hughes, MD, et al.
Published: (2024-12-01)

Comparing effectiveness of tissue and plasma plasminogen activator thrombolysis in patients with various severity of acute myocardial infarction
by: V. A. Shulman, et al.
Published: (2005-12-01)

Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
by: Najib M Rahman, et al.
Published: (2019-10-01)

Intrapleural tissue plasminogen activator and deoxyribonuclease in complex pleural effusion and empyema, clinical outcomes, and predictors
by: Yub Raj Sedhai, et al.
Published: (2025-05-01)

Free Flap Salvage Using Extracorporeal Tissue Plasminogen Activator Administration: A Comparative Study
by: Anna Johansen, MS, et al.
Published: (2025-06-01)

Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections
by: Jason R. McClune, et al.
Published: (2016-01-01)

Effect of Plasma Soluble Urokinase-Type Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 Levels in the Plasma of Babylon Women with Breast Cancer
by: Sheerin H. Abbas, et al.
Published: (2025-01-01)

A nomogram model for prognosis of acute ischemic stroke treated with recombinant tissue-type plasminogen activator
by: Song Bai, et al.
Published: (2025-05-01)

Imaging Evidence for Cerebral Hyperperfusion Syndrome after Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
by: Yi Zhang, et al.
Published: (2016-01-01)

Tissue plasminogen activator modified thromboelastography identifies fibrinolysis resistance in dogs with immune-mediated hemolytic anemia
by: Robert Goggs, et al.
Published: (2025-06-01)

Plasma tissue plasminogen activator-inhibitor complex levels in acute myocardial infarction patients: an observational study
by: Yi-fan Feng, et al.
Published: (2024-12-01)

The Association Between Recombinant Tissue Plasminogen Activator and Post-ischemic Stroke Seizure: A Retrospective Cohort Study
by: Hanie Khoshtarash, et al.
Published: (2025-07-01)

Correlation between subretinal tissue plasminogen activator and air injection rates with pressure in a retina mimicking model
by: Na Hee Kim, et al.
Published: (2024-10-01)

The von Willebrand Factor Collagen-Binding Activity, the Concentrations of Tissue-type Plasminogen Activator and Its Inhibitor in Patients with Mechanical Injury
by: P. V. Gromov, et al.
Published: (2009-08-01)

Evaluating tissue plasminogen activator (tPA) in dialysis catheter dysfunction: A focus on fibrin sheath and risk factors
by: Javad Jalili, et al.
Published: (2025-10-01)

Endovascular thrombectomy versus intravenous tissue plasminogen activator for vertebrobasilar stroke treatment: insights from the national inpatient sample
by: Ram Saha, et al.
Published: (2025-04-01)

Prothrombotic Effect of Anti-beta-2 Glycoprotein-1 Antibodies on the Expression of Tissue Factor, Thrombomodulin, and Plasminogen Activator Inhibitor-1 in Endothelial Cells
by: Rikarni Rikarni, et al.
Published: (2015-03-01)

Prothrombotic Effect of Anti-beta-2 Glycoprotein-1 Antibodies on the Expression of Tissue Factor, Thrombomodulin, and Plasminogen Activator Inhibitor-1 in Endothelial Cells
by: Rikarni Rikarni, et al.
Published: (2015-03-01)

Activity of Yeast Cells Solubilized in a Water-in-Oil Microemulsion
by: Alejandro Hochköppler, et al.
Published: (1989-11-01)

Upregulation of Plasminogen Activator Inhibitor-1 in Irradiated Recipient Arteries and Veins from Free Tissue Transfer Reconstruction in Cancer Patients
by: Bjorn O. Eriksson, et al.
Published: (2018-01-01)

Cerebral arterial collateral status, but not venous outflow profiles, modifies the effect of intravenous tissue plasminogen activator in acute ischemic stroke
by: Elif Sarionder Gencer, et al.
Published: (2024-12-01)

ISOLATION OF PHOSPHOROUS SOLUBILIZING BACTERIA AND FUNGI FROM RHIZOSPHERE AND ITS EFFICIENCY ON ROCK PHOSPHATE SOLUBILIZATION
by: Mazin F. Said
Published: (2006-12-01)

Recombinant tissue plasminogen activator protects neurons after intracerebral hemorrhage through activating the PI3K/AKT/mTOR pathway
by: Jie Jing, et al.
Published: (2026-04-01)

Phosphate solubilization capacity by bacteria in soybean crops
by: R. T. Vey, et al.
Published: (2025-07-01)

Urokinase-Type Plasminogen Activator System in Norm and in Life-Threatening Processes (Review)
by: Elena V. Kugaevskaya, et al.
Published: (2018-12-01)

Involvement of Urokinase-Type Plasminogen Activator Receptor in the Formation of a Profibrotic Microenvironment in the Epicardial Region
by: K. V. Dergilev, et al.
Published: (2021-12-01)

Plasminogen Activator Inhibitors in Thrombosis: Structural Analysis and Potential Natural Inhibitors
by: Roney V. dos Santos, et al.
Published: (2025-06-01)

Utilization of a Parental Approach to Informed Consent in Intravenous Tissue Plasminogen Activator Administration Decision-Making: Patient Preference and Ethical Considerations
by: Ann M. Murray, et al.
Published: (2019-01-01)

Synergistic effects of neuroprotective drugs with intravenous recombinant tissue plasminogen activator in acute ischemic stroke: A Bayesian network meta-analysis.
by: Chun Dang, et al.
Published: (2024-01-01)